The "3rd generation" chimeric immune receptor engineered T cells: Can we improve adoptive immunother...
The "3rd generation" chimeric immune receptor engineered T cells: Can we improve adoptive immunotherapy strategies against glioblastoma?
About this item
Full title
Author / Creator
Sahin, A , Maxfield, S , Bullain, S , Sanchez, C , Baratta, E and Carter, B S
Journal title
Language
English
Formats
More information
Scope and Contents
Contents
The CIR (chimeric immune receptor) technology is based on the redirection of immune effector cells toward a selected target using chimeric receptors that are linked directly to the signaling domain of the endogenous T cell receptor (TCR). Using this technology, we previously engineered a "1st generation" CIR targeting EGFRvIII mutant protein (MRI-C...
Alternative Titles
Full title
The "3rd generation" chimeric immune receptor engineered T cells: Can we improve adoptive immunotherapy strategies against glioblastoma?
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_19412448
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_19412448
Other Identifiers
ISSN
1043-0342
